Down -21.69% in 4 Weeks, Here's Why Tandem Diabetes Care (TNDM) Looks Ripe for a Turnaround
France Diabetes Devices Market Report (2024-2032) With Analysis by Type, Distribution Channel and Company - BD, Medtronic, Tandem Diabetes Care, Novo Nordisk, Roche, Abbott Labs, Eli Lilly, Ypsomed, Dexcom
Stifel Maintains Tandem Diabetes Care(TNDM.US) With Buy Rating, Maintains Target Price $60
Tandem Diabetes Care: Hold Rating Reiterated Amidst Market Challenges and Slow Product Uptake
RBC Capital Maintains Tandem Diabetes Care(TNDM.US) With Buy Rating, Maintains Target Price $65
Tandem Diabetes Care Inc (TNDM) Q2 2024 Earnings Call Highlights: Strong Sales Growth and ...
Medtronic Issues Recall for MiniMed Insulin Pumps Over Battery Issues
This MINISO Group Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Friday
Goldman Sachs Initiates Tandem Diabetes Care(TNDM.US) With Hold Rating, Announces Target Price $46
Analysts Offer Insights on Healthcare Companies: Edwards Lifesciences (EW), Tandem Diabetes Care (TNDM) and BioMarin Pharmaceutical (BMRN)
Press Release: Tandem Diabetes Care to Announce Third Quarter 2024 Financial Results on November 6, 2024
Express News | Tandem Diabetes Care to Announce Third Quarter 2024 Financial Results on November 6, 2024
Tandem Diabetes Insulin Pump Demand to Surge Despite Popular Demand Of Weight Loss Drugs, Bullish Analyst Says
RBC Capital Initiates Tandem Diabetes Care(TNDM.US) With Buy Rating, Announces Target Price $65
Express News | Tandem Diabetes Care Inc : RBC Initiates Coverage With Outperform Rating; Target Price $65
BDX Upped to Buy by Citi, TNDM Put on Negative Catalyst Watch
Citi Maintains Tandem Diabetes Care(TNDM.US) With Buy Rating, Maintains Target Price $57
Tandem Diabetes Care (NASDAQ:TNDM) Advances 4.7% This Week, Taking One-year Gains to 115%
Morgan Stanley Maintains Equal-Weight on Tandem Diabetes Care, Maintains $45 Price Target
Tandem Diabetes Care Analyst Ratings